CASP3 and non-small cell lung carcinoma: Despite the high level of concentration- and time-dependent synergized cell death observed by SRB assay during the first 24 h of SBO and DTX treatment, no remarkable caspase-3 cleavage was observed in either SBO or combination treatment groups in both NSCLC cells (Figure 7a,b).